Hematology Oncology Services of Arkansas SC

Little Rock, Arkansas 72205

0 studies enrolling now · 2 studies all time

What they study most

Chronic Myelogenous Leukemia, Neoplasms

Studies at this site

• An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment — Completed
• Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study. — Completed